Selective Laser Sintering for Solid Pharmaceutical Dosage Forms

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current 3D printing technologies, such as FDM, are not suitable for producing a wide variety of dosage forms like films or fast-dissolving tablets for sublingual administration, limiting their application in drug formulation.

Innovation Solution

Powder bed fusion selective laser 3D printing is used to create solid pharmaceutical dosage formulations by sintering a mixture of drugs and excipients, where at least one component absorbs electromagnetic radiation, allowing for the production of diverse dosage forms including tamper-resistant forms, immediate release tablets, and buccal films.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If FDM technology is used for 3D printing, then it can produce dosage forms, but it cannot produce films or fast-dissolving tablets for sublingual administration

Engineering Contradiction:
Improvedosage form varietyVSAvoidmanufacturing suitability
Core Design Contradiction:
Adaptability or versatilityVSEase of manufacture

Solution Approach 1:

The patent replaces the mechanical extrusion-based FDM system with a laser-based powder bed fusion system. The laser selectively melts and fuses powder particles according to a digital model, enabling the production of diverse dosage forms including films and fast-dissolving tablets that are not achievable with FDM technology.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent changes the fundamental processing parameters from mechanical extrusion and layer deposition (FDM) to laser irradiation, selective melting, and powder fusion. This parameter change enables the system to produce a wider range of dosage forms with different structural requirements, including thin films and rapidly disintegrating tablets.

Inventive Principle:
Principle #35Parameter changes

2Adaptability or versatility

If powder bed fusion selective laser 3D printing is used, then versatility in dosage forms is improved, but drug or excipient degradation may occur due to laser radiation

Engineering Contradiction:
Improvedosage form varietyVSAvoiddrug stability
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The patent introduces an intermediary approach by using a powder bed system where the laser selectively melts and fuses particles. The powder particles act as a medium that absorbs and distributes the laser energy, enabling controlled fusion while minimizing direct thermal exposure to the drug substance. This intermediary mechanism allows versatility in dosage form production while maintaining drug stability.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method offers greater versatility in drug administration and performance, enabling personalized dosing, tamper-resistant formulations, and rapid disintegration tablets, while maintaining the advantages of 3D printing like unique shapes and personalized medicine.

Implementation Method 1

at least one of said drug and said excipient absorbs electromagnetic radiation at a wavelength emitted by the laser

Methodology Applied
Scientific EffectAbsorption of electromagnetic radiation: Absorption (EM radiation)

Implementation Method 2

powder bed fusion selective laser 3-dimensional printing

Methodology Applied
Scientific EffectLaser: Laser

Implementation Method 3

selective laser sintering 3-dimensional printing

Methodology Applied
Scientific EffectSintering: Sintering

Data Source

PatentUS11464745B2Solid pharmaceutical dosage formulations and processes
Publication Date: 2022.10.11 UCL BUSINESS LTD
  • US11464745B2 patent drawing
  • US11464745B2 patent drawing
  • US11464745B2 patent drawing

AI summary

A process for producing a solid pharmaceutical dosage formulation, said process comprising powder bed fusion selective laser 3-dimensional printing of a mixture comprising: (a)a drug; and (b)an excipient; whereinat least one of said drug and said excipient absorbs electromagnetic radiation at a wavelength emitted by the laser; or (a)a drug; (b)an excipient; and (c)an absorbent material which absorbs electromagnetic radiation at a wavelength emitted by the laser.